Vertex (VERX) remains unprofitable but is narrowing its losses at an average rate of 16.4% per year over the past five years. Looking ahead, the company’s annual revenue is expected to grow by 12.4% ...

The strength of our strategy was evident in our strong cloud revenue growth, the increased margin leverage driven by ...

Sabre is regaining ground after a tough year, President and CEO Kurt Ekert told Skift after the company’s third-quarter ...

A regional bank named Crescent Financial plans to deploy a generative AI assistant on Vertex AI that will analyze sensitive customer records and chat transcripts. The leadership team must guarantee ...

Want to pass the Microsoft AI-102 Azure AI Engineer certification exam on your first try? You are in the right place, because we have put together a collection of sample AI-102 exam questions that ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic ...